Edition:
United States

Bliss GVS Pharma Ltd (BLIS.NS)

BLIS.NS on National Stock Exchange of India

177.25INR
6:18am EDT
Change (% chg)

Rs-11.50 (-6.09%)
Prev Close
Rs188.75
Open
Rs190.90
Day's High
Rs193.90
Day's Low
Rs175.50
Volume
246,235
Avg. Vol
155,321
52-wk High
Rs220.25
52-wk Low
Rs154.25

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Mar-18 1 8,638.00 8,638.00 8,638.00 --
Earnings (per share)
Year Ending Mar-18 1 10.00 10.00 10.00 --
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 591.84 30.49 32.71
P/E High - Last 5 Yrs. 1,099.37 42.04 47.27
P/E Low - Last 5 Yrs. 11.32 23.56 24.80
Beta 0.37 0.90 0.87
Price to Sales (TTM) 5.53 4.35 6.42
Price to Book (MRQ) -- 3.53 3.91
Price to Tangible Book (MRQ) -- 5.09 5.97
Price to Cash Flow (TTM) 37.22 22.24 23.27
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield 0.53 1.83 1.69
Dividend Yield - 5 Year Avg 0.49 1.53 1.45
Dividend 5 Year Growth Rate 7.39 -8.57 -5.70
Payout Ratio(TTM) 54.36 49.39 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -8.97 5.63 8.45
Sales (TTM) vs TTM 1 Yr. Ago -28.36 4.62 6.71
Sales - 5 Yr. Growth Rate -1.25 6.93 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago 3.91 18.71 25.51
EPS (TTM) vs TTM 1 Yr. Ago -89.13 -- --
EPS - 5 Yr. Growth Rate -49.77 6.47 7.60
Capital Spending - 5 Yr. Growth Rate 8.00 7.80 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.19 2.20
Current Ratio (MRQ) -- 2.93 2.97
LT Debt to Equity (MRQ) -- 8.94 11.21
Total Debt to Equity (MRQ) -- 11.22 14.02
Interest Coverage (TTM) 7.34 41.23 35.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 30.21 55.18 54.73
Gross Margin - 5 Yr. Avg. 43.59 53.33 53.30
EBITD Margin (TTM) 24.15 -- --
EBITD - 5 Yr. Avg 27.04 18.71 15.89
Operating Margin (TTM) 9.19 13.37 3.72
Operating Margin - 5 Yr. Avg. 21.56 14.29 11.01
Pre-Tax Margin (TTM) 16.75 13.76 4.04
Pre-Tax Margin - 5 Yr. Avg. 22.45 14.60 11.19
Net Profit Margin (TTM) 9.60 10.38 0.77
Net Profit Margin - 5 Yr. Avg. 13.75 10.89 7.53
Effective Tax Rate (TTM) 42.72 20.48 20.44
Effective Tax Rate - 5 Yr. Avg. 38.75 23.83 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 7,725,478 820,576,740 715,149,750
Net Income/Employee (TTM) 741,346 94,890,309 82,590,366
Receivable Turnover (TTM) -- 5.00 5.01
Inventory Turnover (TTM) -- 2.52 3.61
Asset Turnover (TTM) -- 0.83 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 9.99 9.73
Return on Assets - 5 Yr. Avg. 7.63 11.38 10.90
Return on Investment (TTM) -- 13.04 12.72
Return on Investment - 5 Yr. Avg. 12.87 14.69 14.02
Return on Equity (TTM) -- 14.98 14.84
Return on Equity - 5 Yr. Avg. 10.73 15.89 15.37
  1 Year 3 Year 5 Year
Sales % -8.53 -2.92 -1.25
EPS (TTM) % -91.16 -68.65 -49.77
Dividend % 66.67 12.62 7.39
Note: Units in Millions of US Dollars

Performance for Bliss GVS Pharma Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.13 0.94 99 43
13 Week 1.67 -2.64 99 71
26 Week -3.80 -14.12 99 53
52 Week 17.13 2.24 99 37
YTD -10.97 -18.32 99 42
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.18%
# of Holders: 8
Total Shares Held: 6,371,439
3 Mo. Net Change: -18,135
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 2
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.